Pyridoxine for prevention and treatment of PARP inhibitor induced nausea and vomiting

Poly-ADP ribose polymerase inhibitors (PARPi) are a promising new treatment option for patients with ovarian cancer and are moderately emetogenic. Tolerance of therapy is paramount, and uncontrolled nausea and vomiting may limit use. Although most patients will experience improvement in nausea and v...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostby, Stuart A., Smith, Haller J., Leath, Charles A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722232/
https://www.ncbi.nlm.nih.gov/pubmed/31517011
http://dx.doi.org/10.1016/j.gore.2019.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722232/
https://www.ncbi.nlm.nih.gov/pubmed/31517011
http://dx.doi.org/10.1016/j.gore.2019.07.005

Ejemplares similares